IP Library Granted Patent US 7,423,067
Granted Patent B2
US 7,423,067 · App. 10/507,864 · Granted Sep 9, 2008

Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,423,067
App. No.
10/507,864
Granted
Sep 9, 2008
Kind
B2
Abstract

Novel compounds of structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as psychotropic drugs in the treatment of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinsons disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as, the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, and cirrhosis of the liver.

Claims (242)

1. A compound of structural formula I:

or a pharmaceutically acceptable salt thereof, wherein:

R 1 is phenyl, wherein phenyl is substituted with one, two, three or four substituents independently selected from R b ;

R 2 is phenyl, wherein phenyl is optionally substituted with one, two, three or four substituents independently selected from R b ;

R 3 is methyl;

R 4 is selected from:

(1) hydrogen,

(2) methyl,

(3) —OH,

(4) —O-phenyl,

(5) —NH 2 ,

(6) —NH-phenyl,

(7) —NH(CO)O-alkyl,

(8) phenyl, and

(9) pyridyl,

wherein methyl and alkyl are optionally substituted with one, two, three or four substituents independently selected from R a , and phenyl and pyridyl are optionally substituted with one, two, three or four substituents independently selected from R b ;

R 6 is hydrogen;

A is

each R a is independently selected from:

(1) —OR c ,

(2) halogen,

(3) —S(O) m R c ,

(4) —SR c ,

(5) —C(O)R c ,

(6) —CO 2 R i ,

(7) —CN,

(8) CF 3 , and

(9) oxo;

each R b is independently selected from:

(1) R a ,

(2) methyl,

(3) ethyl,

(4) propyl,

(5) phenyl,

(6) benzyl, and

(7) pyridyl;

each R c is independently selected from:

(1) C 1-10 alkyl, and

(2) phenyl

R i is

(1) C 1-10 alkyl; and

m is 2.

2. The compound according to claim 1 wherein:

each R a is independently selected from:

(1) —OR c

(2) halogen,

(3) —S(O) m R c ,

(4) —SR c ,

(5) —C(O)R c ,

(6) —CN,

(7) CF 3 , and

(8) oxo;

or a pharmaceutically acceptable salt thereof.

3. The compound according to claim 2 wherein:

R 1 is phenyl, wherein phenyl is optionally substituted with one, to substituents independently selected from R b ;

R 2 is phenyl, wherein phenyl is independently with one to three R b substituents;

each R b is independently selected from:

(1) R a , and

(2) methyl,

or a pharmaceutically acceptable salt thereof.

4. The compound according to claim 3 wherein:

R 1 and R 2 are independently selected from:

(1) phenyl,

(2) 4-fluorophenyl,

(3) 2-chlorophenyl,

(4) 3-chlorophenyl,

(5) 4-chlorophenyl,

(6) 3-cyanophenyl,

(7) 4-cyanophenyl,

(8) 4-methylphenyl,

(9) 4-isopropylphenyl,

(10) 4-bromophenyl,

(11) 4-iodophenyl,

(12) 2,4-dichlorophenyl, and

(13) 2-chloro4-fluorophenyl;

or a pharmaceutically acceptable salt thereof.

5. A compound selected from:

(1) N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-3-benzoyl-cyclopentane-carboxamide;

(2) N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-cyclopentanone-3-carboxamide;

(3) N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-1-(3-pyridyl)-cyclopentane-carboxamide;

(4) N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-1-(phenylamino)-cyclopentanecarboxamide;

(5) N-[3-(4-chlorophenyl)-2-phenyl-1-methylpropyl]-1-phenylcyclopentanecarboxamide;

(6) N-[3-(4-chlorophenyl)-2-phenyl-1-methylpropyl]-1-(3,5-difluorophenyl)cyclopentanecarboxamide;

(7) N-[3-(4-chlorophenyl)-2-phenyl-1-methylpropyl]-1-(4-pyridyl)cyclopentanecarboxamide;

(8) N-[3-(4-chlorophenyl)-2-phenyl-1-methylpropyl]-1-(3-pyridyl)cyclopentanecarboxamide;

(9) N-[3-(4-chlorophenyl)-2-phenyl-1-methylpropyl]-1-(3-pyridyl)cyclopentanecarboxamide;

(10) N-[3-(4-chlorophenyl)-2-phenyl-1-methylpropyl]-1-(3-pyridyl-N-oxide)cyclopentanecarboxamide;

(11) N-[3-(4-chlorophenyl)-2-phenyl-1-methylpropyl]-1-(2-pyridyl)cyclopentanecarboxamide;

(12) N-[3-(4-chlorophenyl)-2-phenyl-1-methylpropyl]-1-(5-bromo-3-pyridyl)cyclopentanecarboxamide;

(13) N-[2,3-bis(4-chlorophenyl)-1-methylpropyl]-1-(tert-butoxycarbonylamino)cyclohexane-carboxamide;

(14) N-[2,3-bis(4-chlorophenyl)-1-methylpropyl]-1-aminocyclohexanecarboxamide;

(15) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(5-bromo-3-pyridyl)cyclopentanecarboxamide;

(16) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-fluorophenyl)cyclopentanecarboxamide;

(17) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(3-fluorophenyl)cyclopentanecarboxamide;

(18) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-fluorophenyl)cyclopentanecarboxamide;

(19) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-chloro-6-fluorophenyl)cyclopentanecarboxamide;

(20) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-chlorophenyl)cyclopentanecarboxamide;

(21) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-methylphenyl)cyclopentanecarboxamide;

(22) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-methoxyphenyl)cyclopentanecarboxamide;

(23) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(3-pyridyl)cyclopentanecarboxamide;

(24) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-phenylcyclopentanecarboxamide;

(25) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-pyridyl)cyclopentanecarboxamide;

(26) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-chloro-4-fluorophenyl)cyclopentanecarboxamide;

(27) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2,4-dichlorophenyl)cyclopentanecarboxamide;

(28) N-(2S,3S)-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(3-pyridyl)cyclopentanecarboxamide;

(29) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(5-bromo-3-pyridyl)cyclopentanecarboxamide;

(30) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(5-bromo-3-pyridyl)cyclopentanecarboxamide;

(31) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-fluorophenyl)cyclopentanecarboxamide;

(32) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-fluorophenyl)cyclopentanecarboxamide;

(33) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(3-fluorophenyl)cyclopentanecarboxamide;

(34) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(3-fluorophenyl)cyclopentanecarboxamide;

(35) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-fluorophenyl)cyclopentanecarboxamide;

(36) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-fluorophenyl)cyclopentanecarboxamide;

(37) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-chloro-6-fluorophenyl)cyclopentanecarboxamide;

(38) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-chloro-6-fluorophenyl)cyclopentanecarboxamide;

(39) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-chlorophenyl)cyclopentanecarboxamide;

(40) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-chlorophenyl)cyclopentanecarboxamide;

(41) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-methylphenyl)cyclopentanecarboxamide;

(42) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-methylphenyl)cyclopentanecarboxamide;

(43) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-methoxyphenyl)cyclopentanecarboxamide;

(44) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-phenylcyclopentanecarboxamide;

(45) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-phenylcyclopentanecarboxamide;

(46) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-chloro-4-fluorophenyl)cyclopentanecarboxamide;

(47) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-chloro-4-fluorophenyl)cyclopentanecarboxamide;

(48) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2,4-dichlorophenyl)cyclopentanecarboxamide;

(49) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2,4-dichlorophenyl)cyclopentanecarboxamide;

or a pharmaceutically acceptable salt thereof.

6. The compound according to claim 5 selected from:

(1) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(5-bromo-3-pyridyl)cyclopentanecarboxamide;

(2) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-fluorophenyl)cyclopentanecarboxamide;

(3) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(3-fluorophenyl)cyclopentanecarboxamide;

(4) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-fluorophenyl)cyclopentanecarboxamide;

(5) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-chloro-6-fluorophenyl)cyclopentanecarboxamide;

(6) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-chlorophenyl)cyclopentanecarboxamide;

(7) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-methylphenyl)cyclopentanecarboxamide;

(8) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-methoxyphenyl)cyclopentanecarboxamide;

(9) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(3-pyridyl)cyclopentanecarboxamide;

(10) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-phenylcyclopentanecarboxamide;

(11) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-pyridyl)cyclopentanecarboxamide;

(12) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-chloro-4-fluorophenyl)cyclopentanecarboxamide;

(13) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2,4-dichlorophenyl)cyclopentanecarboxamide;

(14) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(5-bromo-3-pyridyl)cyclopentanecarboxamide;

(15) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(5-bromo-3-pyridyl)cyclopentanecarboxamide;

(16) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-fluorophenyl)cyclopentanecarboxamide;

(17) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-fluorophenyl)cyclopentanecarboxamide;

(18) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(3-fluorophenyl)cyclopentanecarboxamide;

(19) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(3-fluorophenyl)cyclopentanecarboxamide;

(20) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-fluorophenyl)cyclopentanecarboxamide;

(21) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-fluorophenyl)cyclopentanecarboxamide;

(22) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-chloro-6-fluorophenyl)cyclopentanecarboxamide;

(23) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-chloro-6-fluorophenyl)cyclopentanecarboxamide;

(24) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-chlorophenyl)cyclopentanecarboxamide;

(25) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-chlorophenyl)cyclopentanecarboxamide;

(26) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-methylphenyl)cyclopentanecarboxamide;

(27) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-methylphenyl)cyclopentanecarboxamide;

(28) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(4-methoxyphenyl)cyclopentanecarboxamide;

(29) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-phenylcyclopentanecarboxamide;

(30) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-phenylcyclopentanecarboxamide;

(31) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-chloro-4-fluorophenyl)cyclopentanecarboxamide;

(32) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2-chloro-4-fluorophenyl)cyclopentanecarboxamide;

(33) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2,4-dichlorophenyl)cyclopentanecarboxamide;

(34) N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-1-(2,4-dichlorophenyl)cyclopentanecarboxamide;

or a pharmaceutically acceptable salt thereof.

7. A compound of structural formula:

or a pharmaceutically acceptable salt thereof, wherein:

R 1 is phenyl, wherein phenyl is optionally substituted with one, two, three or four substituents independently selected from R b ;

R 2 is phenyl, wherein phenyl is optionally substituted with one, two, three or four substituents independently selected from R b ;

R 3 is methyl;

R 4 is selected from:

(1) hydrogen,

(2) —NH 2 ,

(3) —NH-phenyl ,

(4) —NH(CO)O-alkyl,

(5) phenyl, and

(6) pyridyl ,

wherein methyl and alkyl, are optionally substituted with one, two, three or four substituents independently selected from R a , and phenyl and pyridyl are optionally substituted with one, two, three or four substituents independently selected from R b ;

A is

each R a is independently selected from:

(1) —OR c ,

(2) halogen,

(3) —SR c ,

(4) —CO 2 R c ,

(5) —CO 2 R i ,

(6) —CN, and

(7) oxo;

each R b is independently selected from:

(1) R a , and

(2) C 1-10 alkyl,

each R c is independently selected from:

(1) C 1-10 alkyl, and

(2) phenyl; and

m is 2.

8. The compound of claim 7 wherein:

each R a is independently selected from:

(1) —OR c

(2) halogen,

(3) —SR c ,

(4) —C(O)R c ,

(5) —CN, and

(6) oxo;

or a pharmaceutically acceptable salt thereof.

9. The compound of claim 8 wherein:

R 1 and R 2 are independently selected from:

(1) phenyl,

(2) 4-fluorophenyl,

(3) 2-chlorophenyl,

(4) 3-chlorophenyl,

(5) 4-chlorophenyl,

(6) 4-cyanophenyl,

(7) 4-methylphenyl,

(8) 4-isopropylphenyl,

(9) 4-bromophenyl,

(10) 4-iodophenyl,

(11) 2,4-dichlorophenyl, and

(12) 2-chloro-4-fluorophenyl;

or a pharmaceutically acceptable salt thereof.

10. The compound of claim 9 wherein:

R 1 and R 2 are independently selected from phenyl and 4-chlorophenyl;

or a pharmaceutically acceptable salt thereof.

11. A compound selected from:

(1) N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-3-benzoyl-cyclopentane-carboxamide;

(2) N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-cyclopentanone-3-carboxamide;

(3) N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-1-(3-pyridyl)-cyclopentane-carboxamide;

(4) N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-1-(phenylamino)-cyclopentanecarboxamide;

(5) N-[3-(4-chlorophenyl)-2-phenyl-1-methylpropyl]-1-phenylcyclopentanecarboxamide;

(6) N-[3-(4-chlorophenyl)-2-phenyl-1-methylpropyl]-1-(3,5-difluorophenyl)cyclopentanecarboxamide;

(7) N-[3-(4-chlorophenyl)-2-phenyl-1-methylpropyl]-1-(4-pyridyl)cyclopentanecarboxamide;

(8) N-[3-(4-chlorophenyl)-2-phenyl-1-methylpropyl]-1-(3-pyridyl)cyclopentanecarboxamide;

(9) N-[3-(4-chlorophenyl)-2-phenyl-1-methylpropyl]-1-(3-pyridyl)cyclopentanecarboxamide;

(10) N-[3-(4-chlorophenyl)-2-phenyl-1-methylpropyl]-1-(3-pyridyl-N-oxide)cyclopentanecarboxamide;

(11) N-[3-(4-chlorophenyl)-2-phenyl-1-methylpropyl]-1-(2-pyridyl)cyclopentanecarboxamide;

(12) N-[3-(4-chlorophenyl)-2-phenyl-1-methylpropyl]-1-(5-bromo-3-pyridyl)cyclopentanecarboxamide;

(41) N-[2,3-bis(4-chlorophenyl)-1-methylpropyl]-1-(tert-butoxycarbonylamino)cyclohexane-carboxamide;

(13) N-[2,3-bis(4-chlorophenyl)-1-methylpropyl]-1-(tert-butoxycarbonylamino)cyclopentane-carboxamide; and

(14) N-[2,3-bis(4-chlorophenyl)-1-methylpropyl]-1-aminocyclohexanecarboxamide;

or a pharmaceutically acceptable salt thereof.

12. The compound according to claim 11 selected from:

(1) N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-1-(3-pyridyl)-cyclopentane-carboxamide; and

(2) N-[2,3-bis(4-chlorophenyl)-1-methylpropyl]-1-(tert-butoxycarbonylamino)cyclohexane-carboxamide;

or a pharmaceutically acceptable salt thereof.

13. A composition comprising a compound according to claim 1 and a pharmaceutically acceptable carrier.

14. A composition comprising a compound according to claim 5 and a pharmaceutically acceptable carrier.

Assignments (2)
CHANGE OF NAME Recorded Jan 29, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023861/0910 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2005
From: HAGMANN, WILLIAM K.; LIN, LINUS S.; SHAH, SHRENIK K.; GOULET, MARK T.; JEWELL, JAMES P.
To: MERCK & CO., INC.
Reel/Frame 015844/0579 →